Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3).

Zingg W, Storr J, Park BJ, Jernigan JA, Harbarth S, Grayson ML, Tacconelli E, Allegranzi B, Cardo D, Pittet D; 2017 Geneva-IPC Think Tank.

Antimicrob Resist Infect Control. 2019 May 10;8:74. doi: 10.1186/s13756-019-0528-0. eCollection 2019.

2.

Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study.

Saris K, Meis JF, Baño JR, Tacconelli E, van de Belt TH, Voss A.

J Fungi (Basel). 2019 Jun 4;5(2). pii: E44. doi: 10.3390/jof5020044.

3.

Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study.

Tacconelli E, Górska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, Huson DH, Carević B, Preoţescu L, Carmeli Y, Kazma M, Spanu T, Carrara E, Malhotra-Kumar S, Gladstone BP.

Clin Microbiol Infect. 2019 May 22. pii: S1198-743X(19)30247-2. doi: 10.1016/j.cmi.2019.05.013. [Epub ahead of print]

PMID:
31128285
4.

Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe.

Tacconelli E, Buhl M, Humphreys H, Malek V, Presterl E, Rodriguez-Baño J, Vos MC, Zingg W, Mutters NT; EUCIC StopNegative group.

BMJ Open. 2019 May 19;9(5):e027683. doi: 10.1136/bmjopen-2018-027683.

5.

Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients.

Nicolè S, Lanzafame M, Lattuada E, Luise D, Vecchi M, Tacconelli E, Vento S.

Infect Dis (Lond). 2019 May 12:1-3. doi: 10.1080/23744235.2019.1609078. [Epub ahead of print] No abstract available.

PMID:
31081419
6.

Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study.

Rizzardo S, Lanzafame M, Lattuada E, Bragantini D, Nicolè S, Calza L, Tacconelli E.

Int J STD AIDS. 2019 Apr;30(5):467-471. doi: 10.1177/0956462418817049. Epub 2019 Jan 10.

PMID:
30999834
7.

Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections.

Tacconelli E, Cataldo MA, Mutters NT, Carrara E, Bartoloni A, Raglio A, Cauda R, Mantengoli E, Luzzaro F, Pan A, Beccara LA, Pecile P, Tinelli M, Rossolini GM.

Int J Antimicrob Agents. 2019 Jul;54(1):49-54. doi: 10.1016/j.ijantimicag.2019.04.007. Epub 2019 Apr 12.

PMID:
30986523
8.

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.

Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J.

Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.

9.

Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals.

Rohde AM, Zweigner J, Wiese-Posselt M, Schwab F, Behnke M, Kola A, Obermann B, Knobloch JK, Feihl S, Querbach C, Gebhardt F, Mischnik A, Ihle V, Schröder W, Armean S, Peter S, Tacconelli E, Hamprecht A, Seifert H, Vehreschild MJGT, Kern WV, Gastmeier P; DZIF-ATHOS study group.

Antimicrob Resist Infect Control. 2018 Dec 27;7:159. doi: 10.1186/s13756-018-0452-8. eCollection 2018.

10.

Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone".

Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02184-18. doi: 10.1128/AAC.02184-18. Print 2018 Dec. No abstract available.

11.

ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus.

Dyar OJ, Beović B, Pulcini C, Tacconelli E, Hulscher M, Cookson B; ESCMID generic competencies working group.

Clin Microbiol Infect. 2019 Jan;25(1):13-19. doi: 10.1016/j.cmi.2018.09.022. Epub 2018 Nov 8.

12.

Public health burden of antimicrobial resistance in Europe.

Tacconelli E, Pezzani MD.

Lancet Infect Dis. 2019 Jan;19(1):4-6. doi: 10.1016/S1473-3099(18)30648-0. Epub 2018 Nov 5. No abstract available.

13.

Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae.

Carrara E, Bragantini D, Tacconelli E.

Curr Opin Infect Dis. 2018 Dec;31(6):594-599. doi: 10.1097/QCO.0000000000000495.

PMID:
30299357
14.

ESCMID white paper: a guide on ESCMID guidance documents.

Scudeller L, Rodríguez-Baño J, Zinkernagel A, Tacconelli E, Akova M, Friedrich AW, Sanguinetti M, Paul M, Poljak M.

Clin Microbiol Infect. 2019 Feb;25(2):155-162. doi: 10.1016/j.cmi.2018.08.005. Epub 2018 Aug 24.

PMID:
30145398
15.

Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.

Temkin E, Fallach N, Almagor J, Gladstone BP, Tacconelli E, Carmeli Y; DRIVE-AB Consortium.

Lancet Glob Health. 2018 Sep;6(9):e969-e979. doi: 10.1016/S2214-109X(18)30278-X.

16.

Remarkable geographical variations between India and Europe in carriage of the staphylococcal surface protein-encoding sasX/sesI and in the population structure of methicillin-resistant Staphylococcus aureus belonging to clonal complex 8.

De Backer S, Xavier BB, Vanjari L, Coppens J, Lammens C, Vemu L, Carevic B, Hryniewicz W, Jorens P, Kumar-Singh S, Lee A, Harbarth S, Schrenzel J, Tacconelli E, Goossens H, Malhotra-Kumar S.

Clin Microbiol Infect. 2019 May;25(5):628.e1-628.e7. doi: 10.1016/j.cmi.2018.07.024. Epub 2018 Aug 2.

PMID:
30076977
17.

Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.

Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E.

Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7. Review.

PMID:
29990487
18.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M; REIPI/ESGBIS/INCREMENT investigators.

Int J Antimicrob Agents. 2018 Nov;52(5):577-585. doi: 10.1016/j.ijantimicag.2018.06.018. Epub 2018 Jun 30.

PMID:
29969692
19.

Social media posts and online search behaviour as early-warning system for MRSA outbreaks.

van de Belt TH, van Stockum PT, Engelen LJLPG, Lancee J, Schrijver R, Rodríguez-Baño J, Tacconelli E, Saris K, van Gelder MMHJ, Voss A.

Antimicrob Resist Infect Control. 2018 May 30;7:69. doi: 10.1186/s13756-018-0359-4. eCollection 2018.

20.

BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.

Solbach P, Chhatwal P, Woltemate S, Tacconelli E, Buhl M, Gerhard M, Thoeringer CK, Vehreschild MJGT, Jazmati N, Rupp J, Manns MP, Bachmann O, Suerbaum S.

PLoS One. 2018 May 8;13(5):e0196977. doi: 10.1371/journal.pone.0196977. eCollection 2018.

21.

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.

Scheuerman O, Schechner V, Carmeli Y, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Molina J, Hernández-Torres A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Navarro-San Francisco C, Bonomo RA, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT investigators.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):660-667. doi: 10.1017/ice.2018.63. Epub 2018 Apr 5.

PMID:
29618394
22.

Is there still a role for vancomycin in skin and soft-tissue infections?

Savoldi A, Azzini AM, Baur D, Tacconelli E.

Curr Opin Infect Dis. 2018 Apr;31(2):120-130. doi: 10.1097/QCO.0000000000000432.

PMID:
29283952
23.

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group.

Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.

PMID:
29276051
24.

Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control.

Magiorakos AP, Burns K, Rodríguez Baño J, Borg M, Daikos G, Dumpis U, Lucet JC, Moro ML, Tacconelli E, Simonsen GS, Szilágyi E, Voss A, Weber JT.

Antimicrob Resist Infect Control. 2017 Nov 15;6:113. doi: 10.1186/s13756-017-0259-z. eCollection 2017.

25.

Hospital antimicrobial stewardship: the way forward - Authors' reply.

Tacconelli E, Gladstone BP.

Lancet Infect Dis. 2017 Nov;17(11):1120-1121. doi: 10.1016/S1473-3099(17)30581-9. No abstract available.

PMID:
29115259
26.

Surveillance for control of antimicrobial resistance.

Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, Sharland M, Rajendran NB, Rodríguez-Baño J; EPI-Net COMBACTE-MAGNET Group.

Lancet Infect Dis. 2018 Mar;18(3):e99-e106. doi: 10.1016/S1473-3099(17)30485-1. Epub 2017 Nov 5. Review.

PMID:
29102325
27.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J; Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group of Bloodstream Infections and Sepsis (ESGBIS)/INCREMENT Group.

Clin Infect Dis. 2017 Oct 30;65(10):1615-1623. doi: 10.1093/cid/cix606.

28.

Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans.

Schrijver R, Stijntjes M, Rodríguez-Baño J, Tacconelli E, Babu Rajendran N, Voss A.

Clin Microbiol Infect. 2018 Jun;24(6):577-590. doi: 10.1016/j.cmi.2017.09.013. Epub 2017 Sep 29. Review.

29.

Evaluation of the scientific impact of the Ebola epidemic: a systematic review.

Mutters NT, Malek V, Agnandji ST, Günther F, Tacconelli E.

Clin Microbiol Infect. 2018 Jun;24(6):573-576. doi: 10.1016/j.cmi.2017.08.027. Epub 2017 Sep 4. Review.

30.

Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.

Meletiadis J, Turlej-Rogacka A, Lerner A, Adler A, Tacconelli E, Mouton JW; the SATURN Diagnostic Study Group.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00473-17. doi: 10.1128/AAC.00473-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

31.

Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.

Harris PNA, Pezzani MD, Gutiérrez-Gutiérrez B, Viale P, Hsueh PR, Ruiz-Garbajosa P, Venditti M, Tumbarello M, Navarro-Francisco C, Calbo E, Akova M, Giamarellou H, Oliver A, Almirante B, Gasch O, Martínez-Martínez L, Schwaber MJ, Daikos G, Pitout J, Peña C, Hernández-Torres A, Doi Y, Pérez F, Tuon FF, Tacconelli E, Carmeli Y, Bonomo RA, Pascual Á, Paterson DL, Rodríguez-Baño J; ESGBIS/REIPI/INCREMENT Group.

Int J Antimicrob Agents. 2017 Nov;50(5):664-672. doi: 10.1016/j.ijantimicag.2017.08.005. Epub 2017 Aug 3.

PMID:
28782704
32.

Human resources estimates and funding for antibiotic stewardship teams are urgently needed.

Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, Harbarth S, Holmes A, Howard P, Morris AM, Nathwani D, Sharland M, Schouten J, Thursky K, Laxminarayan R, Mendelson M.

Clin Microbiol Infect. 2017 Nov;23(11):785-787. doi: 10.1016/j.cmi.2017.07.013. Epub 2017 Aug 2. No abstract available.

33.

The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.

Núñez-Núñez M, Navarro MD, Palomo V, Rajendran NB, Del Toro MD, Voss A, Sharland M, Sifakis F, Tacconelli E, Rodríguez-Baño J; EPI-Net, Combacte-Magnet and EUCIC Group for SUSPIRE.

Clin Microbiol Infect. 2018 Feb;24(2):105-109. doi: 10.1016/j.cmi.2017.07.014. Epub 2017 Jul 24. Review.

34.

Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use.

Gladstone BP, Cona A, Shamsrizi P, Vilken T, Kern WV, Malek N, Tacconelli E.

PLoS One. 2017 Jul 20;12(7):e0181358. doi: 10.1371/journal.pone.0181358. eCollection 2017.

35.

Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit.

Mutters NT, De Angelis G, Restuccia G, Di Muzio F, Schouten J, Hulscher M, Antonelli M, Tacconelli E.

Int J Antimicrob Agents. 2018 Jan;51(1):65-70. doi: 10.1016/j.ijantimicag.2017.06.020. Epub 2017 Jul 10. Review.

PMID:
28705675
36.

[Erratum to: Antibiotic Stewardship 2.0 : Individualization of therapy].

Pletz MW, Tacconelli E, Welte T.

Internist (Berl). 2017 Aug;58(8):880. doi: 10.1007/s00108-017-0288-y. German. No abstract available.

PMID:
28681069
37.

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.

Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Döbele S, Tacconelli E.

Lancet Infect Dis. 2017 Sep;17(9):990-1001. doi: 10.1016/S1473-3099(17)30325-0. Epub 2017 Jun 16. Review.

PMID:
28629876
38.

ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care.

Poljak M, Akova M, Friedrich AW, Rodríguez-Baño J, Sanguinetti M, Tacconelli E, Zinkernagel A.

Clin Microbiol Infect. 2018 Jan;24(1):1-2. doi: 10.1016/j.cmi.2017.05.024. Epub 2017 Jun 2. No abstract available.

39.

[Antibiotic Stewardship 2.0. Individualization of therapy].

Pletz MW, Tacconelli E, Welte T.

Internist (Berl). 2017 Jul;58(7):657-665. doi: 10.1007/s00108-017-0258-4. Review. German. Erratum in: Internist (Berl). 2017 Aug;58(8):880.

PMID:
28573366
40.

Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review.

Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S.

Clin Infect Dis. 2017 Jul 15;65(2):342-347. doi: 10.1093/cid/cix258. Review.

PMID:
28379311
41.

MRSA decolonization failure-are biofilms the missing link?

Günther F, Blessing B, Tacconelli E, Mutters NT.

Antimicrob Resist Infect Control. 2017 Mar 28;6:32. doi: 10.1186/s13756-017-0192-1. eCollection 2017.

42.

Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review.

Núñez-Núñez M, Navarro MD, Gkolia P, Babu Rajendran N, Del Toro MD, Voss A, Sharland M, Sifakis F, Tacconelli E, Rodríguez-Baño J; Members of the EPI-NET group on behalf of COMBACTE-MAGNET Consortium.

BMJ Open. 2017 Mar 27;7(3):e014538. doi: 10.1136/bmjopen-2016-014538.

43.

Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey.

Maraolo AE, Ong DSY, Cortez J, Dedić K, Dušek D, Martin-Quiros A, Maver PJ, Skevaki C, Yusuf E, Poljak M, Sanguinetti M, Tacconelli E; Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1287-1295. doi: 10.1007/s10096-017-2937-4. Epub 2017 Feb 24.

44.

Fighting the enemy within.

Tacconelli E, Autenrieth IB, Peschel A.

Science. 2017 Feb 17;355(6326):689-690. doi: 10.1126/science.aam6372. No abstract available.

PMID:
28209857
45.

In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.

Mischnik A, Baumert P, Hamprecht A, Rohde AM, Peter S, Feihl S, Knobloch J, Gölz H, Kola A, Obermann B, Querbach C, Willmann M, Gebhardt F, Tacconelli E, Gastmeier P, Seifert H, Kern WV; DZIF-ATHOS Study Group.

J Antimicrob Chemother. 2017 May 1;72(5):1359-1363. doi: 10.1093/jac/dkw577.

PMID:
28108677
46.

Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.

Pulcini C, Tebano G, Mutters NT, Tacconelli E, Cambau E, Kahlmeter G, Jarlier V; EUCIC-ESGAP-EUCAST Selective Reporting Working Group.

Int J Antimicrob Agents. 2017 Feb;49(2):162-166. doi: 10.1016/j.ijantimicag.2016.11.014. Epub 2017 Jan 10.

PMID:
28093208
47.

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, De Cueto M, Viale P, Venditti M, Hernández-Torres A, Oliver A, Martínez-Martínez L, Calbo E, Pintado V, Gasch O, Almirante B, Antonio Lepe J, Pitout J, Akova M, Peña-Miralles C, Schwaber MJ, Tumbarello M, Tacconelli E, Origüen J, Prim N, Bou G, Giamarellou H, Bermejo J, Hamprecht A, Pérez F, Almela M, Lowman W, Hsueh PR, Navarro-San Francisco C, Torre-Cisneros J, Carmeli Y, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2017 Mar 1;72(3):906-913. doi: 10.1093/jac/dkw513.

48.

EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.

Babu Rajendran N, Gladstone BP, Rodríguez-Baño J, Sifakis F, Voss A, Carmeli Y, Burkert FR, Gkolia P, Tacconelli E.

BMJ Open. 2017 Jan 5;7(1):e013634. doi: 10.1136/bmjopen-2016-013634. Erratum in: BMJ Open. 2017 Jan 27;7(1):e013634corr1.

49.

Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.

Mischnik A, Baumert P, Hamprecht A, Rohde A, Peter S, Feihl S, Knobloch J, Gölz H, Kola A, Obermann B, Querbach C, Willmann M, Gebhardt F, Tacconelli E, Gastmeier P, Seifert H, Kern WV; DZIF-ATHOS Study Group.

Int J Antimicrob Agents. 2017 Feb;49(2):239-242. doi: 10.1016/j.ijantimicag.2016.10.013. Epub 2016 Nov 28.

PMID:
27939093
50.

In Reply.

Tacconelli E.

Dtsch Arztebl Int. 2016 Oct 28;113(43):738. doi: 10.3238/arztebl.2016.0738. No abstract available.

Supplemental Content

Loading ...
Support Center